Gene · 60675
Papers1,805
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
161 to 180 of 1,805
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| The double-edged role of neutrophil heterogeneity in inflammatory diseases and cancers. | MedComm (2020) | 2023 | 37492784 | PubTator, text mining | PubMed |
| Feasibility of a Postpartum Web- and Phone-Based Lifestyle Program for Women with a History of Preeclampsia or Gestational Diabetes: A Pilot Intervention Study. | Womens Health Rep (New Rochelle) | 2023 | 37485436 | PubTator, text mining | PubMed |
| Identification of PROK2 gene polymorphisms as predictors of methamphetamine use disorder risk and indicators of craving scale in the Chinese Han population. | Front Pharmacol | 2023 | 37484015 | PubTator, text mining | PubMed |
| Exploration of the shared gene signatures and molecular mechanisms between periodontitis and inflammatory bowel disease: evidence from transcriptome data. | Gastroenterol Rep (Oxf) | 2023 | 37456714 | PubTator, text mining | PubMed |
| LC-MS/MS-Based Serum Metabolomics and Transcriptome Analyses for the Mechanism of Augmented Renal Clearance. | Int J Mol Sci | 2023 | 37445637 | PubTator, text mining | PubMed |
| Prokineticin 2 and Cytokine Content in the Synovial Fluid of Knee Osteoarthritis and Traumatic Meniscal Tear Patients: Preliminary Results. | J Clin Med | 2023 | 37445367 | PubTator, text mining | PubMed |
| Circulating and Tumor-Associated Neutrophils in the Era of Immune Checkpoint Inhibitors: Dynamics, Phenotypes, Metabolism, and Functions. | Cancers (Basel) | 2023 | 37444436 | PubTator, text mining | PubMed |
| Biomarker analysis of the phase II JO25567 study comparing erlotinib with or without bevacizumab in first-line advanced EGFR+non-small-cell lung cancer. | Transl Lung Cancer Res | 2023 | 37425411 | PubTator, text mining | PubMed |
| Blood transcriptomic signatures associated with molecular changes in the brain and clinical outcomes in Parkinson's disease. | Nat Commun | 2023 | 37407548 | PubTator, text mining | PubMed |
| Investigating the correlation between Xrn1-resistant RNAs and frameshifter pseudoknots. | RNA Biol | 2023 | 37400999 | PubTator, text mining | PubMed |
| Recent Advances in Doxorubicin Formulation to Enhance Pharmacokinetics and Tumor Targeting. | Pharmaceuticals (Basel) | 2023 | 37375753 | PubTator, text mining | PubMed |
| Cellular and Molecular Players in the Tumor Microenvironment of Renal Cell Carcinoma. | J Clin Med | 2023 | 37373581 | PubTator, text mining | PubMed |
| Digenic Congenital Hypogonadotropic Hypogonadism Due to Heterozygous GNRH1 p.R31C and AMHR2 p.G445_L453del Variants. | Genes (Basel) | 2023 | 37372384 | PubTator, text mining | PubMed |
| A Gene-Based Algorithm for Identifying Factors That May Affect a Speaker's Voice. | Entropy (Basel) | 2023 | 37372241 | PubTator, text mining | PubMed |
| The ACSL4 Network Regulates Cell Death and Autophagy in Diseases. | Biology (Basel) | 2023 | 37372148 | PubTator, text mining | PubMed |
| PROKR2 Mutations in Patients with Short Stature Who Have Isolated Growth Hormone Deficiency and Multiple Pituitary Hormone Deficiency | J Clin Res Pediatr Endocrinol | 2023 | 37338295 | PubTator, text mining | PubMed |
| Neutrophil-Related Gene Expression Signatures in Idiopathic Pulmonary Fibrosis: Implications for Disease Characteristic and Identification of Diagnostic Hub Genes. | J Inflamm Res | 2023 | 37337515 | PubTator, text mining | PubMed |
| New Approaches to the Synthesis and Stabilization of Polymer Microspheres with a Narrow Size Distribution. | Polymers (Basel) | 2023 | 37299262 | PubTator, text mining | PubMed |
| A case of novel mutation in ANOS1 (KAL1) gene and review of Kallmann syndrome. | Endocrinol Diabetes Metab Case Rep | 2023 | 37294556 | PubTator, text mining | PubMed |
| Immunometabolic reprogramming, another cancer hallmark. | Front Immunol | 2023 | 37275901 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/60675/papers?page=9